T. Rowe Price Associates »

Viking Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 55k 18.61
2023-09-30 $459k 42k 11.07
2023-06-30 $739k 46k 16.22

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Viking Therapeutics

Vanguard Group
Viking Global Investors
Alliancebernstein
Balyasny Asset Management
Deerfield Management Company
Goldman Sachs Group
Perpetual
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Bank of America Corporation
Eventide Asset Management
Massachusetts Financial Services
683 Capital Management
5AM Venture Management
Citadel Advisors

View all funds holding Viking Therapeutics